Comparison of pharmacokinetic characteristics of two Tegoprazan (CJ-12420) formulations in healthy male subjects

Proton-pump inhibitors (PPIs) are effectively used to treat acid-related diseases, including gastroesophageal reflux disease (GERD); however, many unmet medical needs still exist. As a new treatment option, potassium-competitive acid blockers (P-CABs), such as tegoprazan, have been developed. This s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Jun Gi, Yoo, Hyounggyoon, Lee, Ji Won, Song, Geun Seog, Lee, SeungHwan, Kim, Min-Gul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989242/
https://www.ncbi.nlm.nih.gov/pubmed/32055586
http://dx.doi.org/10.12793/tcp.2019.27.2.80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989242/
https://www.ncbi.nlm.nih.gov/pubmed/32055586
http://dx.doi.org/10.12793/tcp.2019.27.2.80

Ejemplares similares